Hypervirulent Klebsiella pneumoniae (hvKP) strains can cause invasive
liver abscess syndrome, which is characterised by liver abscess with extrahepatic
complications including central nervous system involvement, necrotising fasciitis or
endophthalmitis (Siu et al. 2012). hvKP was first
reported in Taiwan in 1985 and, since then, infections caused by hvKP have been described
in several parts of the world, with many cases reported in Southeast Asia (Li et al. 2014). In the Americas, invasive liver abscess
syndrome has been reported in the United States of America, Canada and Argentina (Siu et al. 2012). However, this strain has not been
previously reported in Brazil. Recently, a 57-year-old woman with diabetes mellitus was
admitted to the emergency department with a history of fever, nausea, vomiting and mental
confusion for five days. On the day of admission, she was comatose, icteric and had a poor
general appearance. Her temperature was 37.8°C and her blood pressure, pulse and
respiratory rate were 110/60 mmHg, 96 beats/min and 48 breaths/min, respectively.
Respiratory and cardiovascular auscultations were normal; however, a neurological
examination revealed neck rigidity. Bacterial meningitis was suspected and ceftriaxone 2 g
IV q12 h was empirically prescribed after performing a diagnostic lumbar puncture. Her
cerebrospinal fluid (CSF) was xanthochromic and showed glucose 0.0 mg/dL, protein 485 mg/dL
and 8,640 cells/mm3 (8,121 neutrophils/mm3 and 259
lymphocytes/mm3). Direct examination of her CSF revealed Gram-negative
bacilli. At admission, she also had the following altered laboratory tests: glycaemia (264
mg/dL), serum creatinine (2.95 mg/dL), blood urea nitrogen (152 mg/dL), alkaline
phosphatase (177 mg/dL), gamma-glutamyl transferase (138 mg/dL), alanine transaminase (50
mg/dL), aspartate transaminase (36 mg/dL), total bilirubin (0.59 mg/dL), indirect bilirubin
(0.18 mg/dL), direct bilirubin (0.41 mg/dL) and international normalised ratio (1.19).
Brain and multiple liver abscesses (segments IV, V and VIII) were detected through brain
and abdominal computed tomography scans. K. pneumoniae grew on blood
(A58300) and CSF (A58301) cultures and both isolates were susceptible to all antimicrobials
tested using a BDPhoenix Automated System. The isolates were then submitted to the Alerta
Laboratory, Federal University of São Paulo for further characterisation. After surgical
drainage of the brain abscess and percutaneous drainage of the liver abscess, the patient’s
clinical condition deteriorated; ceftriaxone was replaced by meropenem 2 g IV q8 h four
days later. Eight days after admission, the patient developed ventilator-associated
pneumonia and K. pneumoniae (also susceptible to all antibiotics tested)
and multidrug-resistant Acinetobacter baumannii were isolated from
semiquantitative tracheal aspirate cultures. Polymyxin B 1.125.000 UI IV q12 h was added to
the meropenem. Fifteen days later, multidrug-resistant A. baumannii
bacteraemia was detected despite the use of broad antimicrobial therapy; thus,
ampicillin-sulbactam 3 g IV q6 h was added to the antimicrobial regimen. At 45 days after
admission, the patient died due to septic shock and A. baumannii was again
recovered from blood culture. The patient had no previous history of cholelithiasis, liver
cirrhosis, malignancies or steroid or chemotherapy use. In addition, the patient had no
history of international travel or known contact with Asian individuals.At Alerta Laboratory, the identification and antimicrobial susceptibility profile of the
K. pneumoniae strains were confirmed by MALDI-TOF and the agar dilution
method. The minimum inhibitory concentration (MIC) results were typically interpreted
according to the CLSI (2013); however, The European
Committee on Antimicrobial Susceptibility Testing (Breakpoint tables for interpretation of
MICs and zone diameters, v.4.0) were used for determining the MIC of polymyxin B. Both
isolates showed susceptibility to all antimicrobials tested: amoxicillin-clavulanate (MIC ≤
4/2 µg/mL), ceftazidime (MIC ≤ 0.25 µg/mL), cefepime (MIC ≤ 0.25 µg/mL), meropenem (MIC ≤
0.06 µg/mL), imipenem (MIC ≤ 0.06 µg/mL), ertapenem (MIC ≤ 0.06 µg/mL), ciprofloxacin (MIC
≤ 0.06 µg/mL), amikacin (MIC 2 µg/mL), tigecycline (MIC 0.25 µg/mL), fosfomycin (MIC 16
µg/mL), piperacillin/tazobactam (MIC 4 µg/mL) and polymyxin B (MIC ≤ 0.125 µg/mL). The
genetic similarity of the strains was evaluated by pulsed field gel electrophoresis (PFGE)
and multilocus sequence typing techniques, as previously described (Tenover et al. 1995, Diancourt et al.
2005). Both strains exhibited identical PFGE patterns and were found to belong to
ST23 (Tenover et al. 1995). Genomic DNA was extracted
from both isolates (QIAamp DNA Mini Kit, Qiagen®) and virulence-encoding genes
were detected by polymerase chain reaction (PCR) followed by DNA sequencing (Table). Both strains presented a hypermucoviscosity
phenotype and possessed magA, rmpA, kfu
and aerobactin genes. MagA is a mucoviscosity-associated gene that is
related to the extensive production of a polysaccharide capsule and increased resistance to
phagocytes. The rmpA gene increases capsular polysaccharide biosynthesis
and mucoviscosity. The kfu gene encodes an iron-uptake system that is
associated with a hypermucoviscosity phenotype and increased virulence (Ma et al. 2005, Hsu et
al. 2011).
TABLE
Factors
evaluated
Target gene
Sequence (5’-3’)
Annealing temperature
(°C)
Amplicom (pb)
References
Mucoviscosity-associated gene A
maga-F
CCGATGGTTGGGTTAGCTTT
60
801
This paper
maga-R
CTGGCCATATTGCTCCGTTG
Regulator of mucoid phenotype
rmpa-F
AGTTAACTGGACTACCTCTGTTTC
60
543
This paper
rmpa-R
TACTTGGCATGAGCCATCTTT
Iron acquisition system
kfu-F
ATAGTAGGCGAGCACCGAGA
60
520
Yu et al. (2008)
kfu-R
AGAACCTTCCTCGCTGAACA
Aerobactin
Aero_1-F
GCATAGGCGGATACGAACAT
60
556
Yu et al. (2008)
Aero_1-R
CACAGGGCAATTGCTTACCT
Aerobactin
Aero_2-F
CTGTCGGCATCGGTTTTATT
60
531
Yu et al. (2008)
Aero_2-R
TGGCGTGTCGATTATTACCA
Thermotolerance phenotype
clpk-F
GTTGTGCGACGACCATTACC
60
557
This paper
clpk-R
TCAGGAAATGCTCTGGACCG
sequence of primers used for amplification of virulence encoding genes
sequence of primers used for amplification of virulence encoding genesAs described in this case report, the patient had the classical clinical and
microbiological characteristics of community-acquired hvKP: liver abscess with metastatic
infections (bacteraemia and meningitis) caused by K. pneumoniae displaying
a hypermucoviscosity phenotype and belonging to capsular serotypes K1 and ST23, with the
presence of the magA and rmpA genes (Chung et al. 2012, Siu et
al. 2012). In addition, the patient was diabetic, a risk factor reported by Siu et al. (2012). This clinical case report is
important for increasing awareness among Brazilian clinicians with regard to the fact that
hvKP ST23 is already circulating in our region and causing serious infections in patients
without any previous history of international travel to Asia.
Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948
Authors: Maria Karlsson; Richard A Stanton; Uzma Ansari; Gillian McAllister; Monica Y Chan; Erisa Sula; Julian E Grass; Nadezhda Duffy; Melissa L Anacker; Medora L Witwer; J Kamile Rasheed; Christopher A Elkins; Alison Laufer Halpin Journal: Antimicrob Agents Chemother Date: 2019-06-24 Impact factor: 5.191